Clinical Trial Update: Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. [NA]

View source ↗

Summary

Clinical trial update assessing liver cancer response to transarterial chemoembolization (TACE) using MultiHance-enhanced MRI in hepatocellular carcinoma; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• MULTIHANCE (Gadobenate dimeglumine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Hepatocellular Carcinoma | NA | Status: COMPLETED | Results posted: 2017-09-26